In recent years, various biochemical investigation techniques, e.g. determination of total estrogens in 24-hour urine, of unconjugated estriol (E 3 ), HPL and other placental steroids in the serum have been applied to a large scale to monitor fetoplacental or placental function [2, 6, 11 5 12, 20] . However, up to the present no single parameter has proved to be the method of choice, probably due to the fact that complex enzymatic Systems or various organs are involved in the synthesis of steroid or protein hormones. Estetrol (15a-estriol, E 4 ) is a specific product of fetal metabolism. The last synthetic Steps depend on the hydroxylation capacity of the fetal liver. Important precursors of E 4 synthesis are estradiol-170 and to a smaller extent neutral C19 steroids of the fetoplacental unit [16, 18, 21] . From the fetus, the hormone passes into the maternal circulation and is mainly excreted äs E 4 -glucuronide in the urine [3] . First investigations in the urine and later also in the blood have shown that this steroid can be regarded äs a good indicator of the fetal state in intrauterine danger [5, 9, 19] . By obtaining specific antisera to E 4 , it has become possible in recent years to determine the low concentration of this steroid in the serum radioimmunologically without time consuming and technically elaborate Separation methods [l, 4, 8, 16, 22] . The objective of the present investigation therefore is to establish in a larger group of patients whether the Curriculum vitae HANS determination of unconjugated E 4 is superior to the measurement of other steroids especially in intrauterine growth retardation, since the significance of hormone assays is chiefly in the diagnosis of intrauterine growth disorders, and can thereby lead to an improvement of the detectiön of fetal danger states.
ifications äs described by KÜNZIG and GEIGER for E 3 [10, 11] . The antiestetrol antiserum was kindly provided by Dr. P. G. D. DEAN [16] . The crossreaction against E 3 is 0.4%, and against all other steroids less than 0.1%. The method can be described briefly äs follows: 0.5 ml of serum are extracted mechanically with 10 ml diethylether for 10 minutes. The tubes are then placed in a methanol bath (-25 °C). After freezing the aqueous phase, the ether is poured into glass test tubes and evaporated with nitrogen. The residue is dissolved with 0.3 ml of ethanol and 2 X 0.1 ml transferred into disposable glass test tubes. The alcohol is evaporated once more and 0.1 ml 2. H-E 4 (specific activity 49 Ci/mM (NEN), 2 X 10"* Mol), äs well äs 0.2 ml -globulin (5 mg/ml) and 0.2 ml anti-E 4 antiserum (l: 14,000) are added (dissolved in phosphate-buffered saline). The test mixtures are incubated for 30 minutes at roöm temperature and at 4 °C, respectively. The antibody-bound and free steroid is separated by addition of 0.5 ml of a charcoal-dextran mixture with subsequent centrifugation. Afterwards, the antibody-bound radioactivity present in the supernatant is measured in a liquid-scintillation counter and the hormone concentration determined with reference t o a Standard curve. The calculation is performed with the aid of a Computer program by means of spline approximation (Fa. BERTHÖLD). The recovery of unlabeled steroids, added to steroid free serum, is 91.9% (n = 22). The intraassay Variation is 8.4% (n = 10) and the interassay precision is 14.8% (n = 10). The lower limit of sensitivity of the Standard curve is 20 pg E 4 .
Patients investigated

1.2.1
The reference ränge for E 4 is determined by 279 determinations between the 22nd and 40th week of pregnancy. The samples derive from different outpatients and inpatients in a random sequence. Any pathology of pregnancy has been excluded.
1.2.2
To determine the variability of the serum level of E 4 , blood was taken from three patients over four hours at an interval of 15 minutes and over 24 hours at an interval of 60 minutes, in 22 patients over 24 hours at an interval of four hours, äs well äs in four patients on five or six consecutive days.
1.2.3
In five patients, the serum E 4 level is determined before, during and after application of betamethasone (8, 8, 4 , 4 mg on four consecutive days), in seven patients who had received an intravenous tocolysis with beta-sympathomimetics, äs well äs in six patients before and up to four days after commencement of a therapy with ampicillin.
1.2.4
A group of 151 patients delivered of babies with signs of intrauterine growth retardation was also investigated. The neonates were subdivided into "small for dates" below the 25th percentile and 'Very small for dates" below the lOth percentile according to LUBCHENKO [13] , äs well äs into neonates with and without signs of dystrophy. The 25th and lOth percentile of the weightcharts of LUBCHENKO are comparable to the lOth and 3rd percentile of the weightcharts of NICKL [2] . Twenty-two and 24 highly retarded eutrophic and dystrophic babies (very small for dates) respectively äs well äs 75 and 24 slightly retarded eutrophic and dystrophic neonates (small for dates) respectively are found. For 55 of the 151 patients, three and more values are between the 30th and 40th week of pregnancy, so that an observation on the concentration course of E 4 is possible. This is made on the basis of the following criteria: 
Results
The serum level of unconjugated E 4 is 0.27 ± 0.06 ng/ml in the 22nd week of pregnancy and rises to 1.37 ± 0.65 ng/ml towards the end of pregnancy. However, a sharper rise of the values only occurs from about the 30th week of pregnancy. There is an appreciable Variation of the individual values (n = 279) of the various patients around the mean value (Fig. 1) (Fig. 2 ). Drugs such äs corticosteroids, 0-sympathomimetics or antibiotics show a distinct influence on the serum E 4 concentration. Within a few hours, there is a decline by an average of 30% compared to the mean initial concentration. With continuation of therapy, the initial value is regained after two to three days with ß-sympathomimetics and after five days with ampicillin, whereas a fresh rise of the values can only be observed after discontinuation of the treatment with corticosteroids (Tab. II). With intrauterine growth retardation below the lOth percentile, the E 4 concentration in the serum displays a characteristic course. As can be seen from Fig. 3b , no appreciable alteration of the values can be detected especially in the last five weeks of pregnancy, in which there is normally a rise of serum E 4 values. At the end of pregnancy, the mean value for 'Very small for dates" (n = 30) with signs of dystrophy is 0.93 ng/ml. For children of the same size without signs of dystrophy (n = 22), it is 0.86 ng/ml, corresponding to 60-70% of the normal. A similar course can also be recognized in "small for dates" with signs of dystrophy (n = 24) (Fig. 3a) . The mean value at the end of pregnancy is 0.83 ng/ml and is thus about 40% below the normal for this stage of pregnancy. On the other hand, the serum level in "small for dates" without signs of dystrophy (n = 75) approximates more to the region of the normal curve and at the end of pregnancy a concentration of 1.20 ng/ml can be detected, i.e. the curve of the mean values practically corresponds to that of babies which have developed normally (Fig.3a) [14] . The solid lines represenl the 90th, 50th, and lOth percontile in normal pregnancy.
However, mean values can only indicate a tend-. ency and for recognition of the diagnostic value of a method it appears meaningful to register the concentration course of individual patients. As can be seen frpm Table 3 , in "very small for dates" with signs of dystrophy pathological courses are present in 70% and in those without signs of dystrophy in 86%. Slightly retarded dystrophic babies frequently also display pathological values (in 66%), whereas eutrophic neonates of the same size reveal normal E 4 levels in 84%. A comparison of the measurement of the well established method of free E 3 compared to E 4 in routine clinical tests shows that pathological E 4 or
• r E 3 values can be detected in eight out of 31 or eight out of 29 "small for dates" respectively. On the other hand, in severe retardation pathological E 4 or E 3 values can be detected in 18 and 17 out 24 babies (Tab. III). A normal concentration of the two hormones can be detected only in three cases out of the "very small for dates", so that in this group thefe is suspicion of an intrauterüie growth retardation in 88% of the cases of this group on the basis of the measurement of both hormones. As a whole, a divergent course of the two hormones can nevertheless be detected in 13 out of 53 cases (25%) (Tab. IV). 
Discussion
Our results show that with specific antisera to E 4 , the radioimmunological determination of this steroid can be used äs a routine method for surveillance of risk pregnancies. From the 22nd to the 30th week of pregnancy, the serum level of E 4 practically does not change with values between 0.24 and 0.37 ng/ml. Then a rise follows, which is intensified once again after the 36th week of pregnancy (surge point) up to the end of pregnancy [9] . Here, the mean value is 1.37 ng/ml. Our values are in accordance with those of other authors [1, 9, 18, 21] who likewise use specific antisera. Only KORDA [7] reports extremely high concentrations around 5 ng/ml at the end of pregnancy; these must be regarded äs methodological in origin. Even with more frequent blood samples, we were unable to detect a diurnal rhythm äs was already suspected by TULCHINSKY et al. [19] äs well äs NOTATION and TAGATZ [15] . Only uncharacteristic fluctuations with a mean coefficient of Variation between 11.7 and 14.5% are found. The dayto-day fluctuations (16.3%) are also in a similar ränge. They thus do not differ significantly from the precision in the series and between the series. Thus the variations of E 4 correspond over short and long time intervals to those of other estrogens and peptides in maternal blood [2, 11] , The daily fluctuations of NOTATION and TAGATZ [15] with in some cases 70% appear inexplicably high; however, an assay method with an unspecific antiserum äs well äs Chromatographie Separation was employed. After application of drugs äs corticosteroids, ß-sympathomimetics or antibiotics (frequently administered in pathological pregnancies), there is a rapid decrease of E 4 concentrations of about 30%, although the values can rise again already under administration of the two latter drugs. These findings correspond to the results already obtained for E 3 on a large scale and appear to be due to comparable pathomechanisms [11] . From this there result important consequences for the Interpretation of the hormone determination in the hospital during treatment with the substances specified above: the absence of a fresh rise or a continuous decrease of the E 4 concentration is not due to therapy, but must be regarded äs a sign of deterioration of fetoplacental function. Since the significance of hormone assays is chiefly in the diagnosis of intrauterine growth disorders, the value of the measurement of E 4 is depicted in the diagnosis of intrauterine growth retardation and the fetal danger states associated with this. In "small for dates" and "very small for dates" with signs of dystrophy, in particular the rise normally taking place in the last weeks of pregnancy cannot be detected and at the end of pregnancy the values are only about 60-70% of those of the normal group (Fig. 3a + b) . In contrast to this, the serum concentration in eutrophic "small for dates" is very much nearer to the normal curve, since these involve genetically small babies withoüt appreciable signs of an intrauterine growth disorder (Fig. 3a) . However, single values can be regarded only äs a "screening test" and a reliable evaluation of the fetoplacental unit is only possible on the basis of serial determinations. Here it is shown that primarily pathological values (< lOth percentile) or a significant decrease of the concentration (> 35%) within the last two weeks of pregnancy indicate a fetal retardation or an acute deterioration of fetoplacental function. This applies to 75% of the "very small for dates" with and withoüt signs of dystrophy (Tab. III). A significant decrease of the E 4 level was also observed by TULCHINSKY et al. [19] in seven patients with severe pre-eclampsia and subsequent fetal death, whereas KUNDU et al. [9] assert a superiority to E 4 compared to determination of E 3 and HPL on the basis of comparative sequential observations. The results of NOTATION and TANGATZ [15] appear to us and also to other authors [9] to be difficult to Interpret already for methodological reasons. Our comparative serial investigations of the assay of E 4 and E 3 in a group of 53 pregnancies with fetal retardation show that the number of suspicious curves of E 4 and E 3 in intrauterine growth retardation is roughly the same and thus the information conveyed is similar (Tab. III). However, only 14 out of 24 highly retarded babies display pathological courses of bothsteroids whereas in a further seven neonates of the same group only one hormone appears to be suspicious. Thus a severe intrauterine growth retardation could be detected with a joint determination in 88% compared to 75% and 71% respectively when E 4 or E 3 was measured alone. Determination of £4 alone thus does not provide a fundamentally new possibility of prenatal diagnosis of jntrauterine growth disorders. However, E 4 appears to be a further diagnostic adjunct similar to E 3 to a certain extent, and use of which can provide a further improvement of our diagnosis. The precondition for this is a further simplification of the laboratory methods, so that after automated determination the joint consideration of various diagnostic methods (similar to internal medicine) enables an early and certain appraisal of the fetal state.
Summary
Within recent years various biochemical tests have been used extensively for assessing the placental and the fetoplacental function. However, atpresent,no single hormone assay seems entirely adequate for this purpose, since complex enzymatic Systems and different organs are involved · \ in the production of steroid and peptide hormones. Estetrol is considered to be a specific product of the fetal liver.
With the recent availability of specific antisera to estetrol it has become possible to measure the small quantities of this steroid by radioimmunoassay without the requirement for prior Chromatographie Separation Steps. Thereby the determination of estetrol can be used äs a routine method on a large scale in high risk pregnancies. In this study we investigated, whether the measurement of this steroid may improve the surveillance of risk pregnancies, especially those complicated by intrauterine growth ret ardation and thereby contribute to the solution of some of the still unsolved problems. The serum concentration of unconjugated estetrol increases from 0,27 ng/ml in the 22nd week of pregnancy to 1,37 ng/ml at term. However Keywords: Drugs, estetrol, estriol, fluctuations, intrauterine growth retardation, normal pregnancy, radioimmunoassay.
Zusammenfassung
Wertigkeit der Bestimmung von Östetrol bei der Diagnostik der intrauterinen Mangelentwicklung. Vergleich mit unkojungiertem Östriol. Dans ce travail-ci on a examine si Festimation d'oestetrollibre dans le sang pouvait etre une amelioration du diagnostic antenatal contemporain, specialement pour le cas de defience de croissance intra-uterine. Le taux le serum d'oestetrol-libre monte de 0,27 ng/ml au moment de la 22 me semaine de grossesse jusqu'a 1,37 ng/ml a la fin de la grossesse, mesure dans un lot de patients pris au hasard. De la il s'ensuit que la montee de la concentration se pioduit surtout durant les 10 dernieres semaines. Par la mesure de taux d'oestetrol dans un delai de 15 min a 24 heures, on trouve des fluctuations nonspecifiques avec un coefficient de Variation moyen d'un minimum de 11,7% et comme maximum 6,3%; un rythme diurne ne peutetre prouve. Des medicaments, comme les corticosteroides, les ß-sympaticomimetiques ou les antibiotiques induisent endeMots-cles: fluctuations, troubles de croissance intra-uterine, medicaments, oestetrol, oestriol, grossesse normale, radioimmunoassay.
ans peu d'heures une chute de la concentration d'oestetrol d'une valeur moyenne de 30% et produisent un effet comparable a celui produit sur lOestriol. On doit en tenir compte dans la surveillance hormonale. Dans la deficience de croissance intra-uterine, la concentration d'E-4 montre un trace caracteristique. L'augmentation durant les dernieres semaines de grossesse n'est pas retrouvee. A la fin de la grossesse la valeur moyenne ne represente que 60-70% des normes chez les enfants fortement retardes avec ou sans signes de dystrophie ainsi que chez des nouveau-nes dystrophiques legerement retardes. La retrospective des examens de 55 grossesses presentant des troubles de croissances intra-uterines, a montre: dans les cas d'enfants gravement retardes avec ou sans signes de dystrophie il y avait de 71% a 86% de traces pathologiques, des enfants dystrophiques legerement retardes avaient des valeurs suspectes dans 66% des cas. Des nouveau-nes eutrophes legerement retardes presentaient dans 84% des cas des taux de steroides normaux. En comparant lors de mesures de routine en clinique, l'oestriol-libre avec l'oestetrol on en deduit que Foestriol et l'oestetrol donnent presque la meme valeur clinique, neanmoins on peut trouver dans 25% des cas une suite divergente. Par la mesure des deux hormones on en arrive a une estimation de 88% des cas suspectes chez les retardes graves, contre 70-75% par le mesure d'une seule hormone. L'estimation d'oestetrol ne remplace les parametres biochimiques utüises jusqu'ä present mais semble etre un test supplementaire dans le diagnostic des troubles de croissance intra-uterine en ameliorant le diagnostic antenatal.
